| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/10/2007 | EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 10/10/2007 | EP1490058B1 Peroxisome proliferator activated receptor modulators |
| 10/10/2007 | EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 10/10/2007 | EP1249450B1 Benzimidazole derivatives as human chymase inhibitors |
| 10/10/2007 | CN101052636A Compound containing fused ring and organic electroluminescent element employing the same |
| 10/10/2007 | CN101052635A Chemical compounds |
| 10/10/2007 | CN101052634A Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 10/10/2007 | CN101052625A Adamantyl derivates as p2x7 receptor antagonists |
| 10/10/2007 | CN101052394A Treatment of acute myeloid leukemia with indolinone compounds |
| 10/10/2007 | CN100341857C Manufacturing method of 6-aminomethyl-6,11-dihydro-5H-dibenzo.[b,e] azepine |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279581 Diazotization of 4-(1,2,4-triazol-1-ylmethyl)phenylamine hydrochloride, reduction and acidification, reaction with hydrazine hydrochloride and alpha -keto- delta -valerolactone, Fischer indole reaction, hydrolysis, transesterification, conversion of hydroxyl group to dimethylamino group |
| 10/09/2007 | US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 10/09/2007 | US7279498 Substituted aryl amides as IP antagonists |
| 10/09/2007 | US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 10/09/2007 | US7279481 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; therapy of depression or anxiety |
| 10/09/2007 | US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation |
| 10/09/2007 | US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device |
| 10/09/2007 | US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea |
| 10/09/2007 | US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression |
| 10/09/2007 | US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/09/2007 | US7279469 Diaminotriazoles useful as inhibitors of protein kinases |
| 10/09/2007 | US7279444 for controlling undesirable plants |
| 10/04/2007 | WO2007111212A1 Triazolone derivative |
| 10/04/2007 | WO2007111024A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 10/04/2007 | WO2007110868A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 10/04/2007 | WO2007110418A2 Substituted 5-hetaryl-4-aminopyrimidines |
| 10/04/2007 | WO2007110374A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/04/2007 | WO2007110344A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 10/04/2007 | WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists |
| 10/04/2007 | WO2007074399A3 Process for the preparation of tetrazolyl compounds |
| 10/04/2007 | WO2007072163A3 Pyrimidine derivatives |
| 10/04/2007 | WO2006100588A8 Substituted triazole derivatives as oxytocin antagonists |
| 10/04/2007 | US20070232808 Process for preparing heterocyclic derivatives |
| 10/04/2007 | US20070232805 Modified carbocyanine dyes and their conjugates |
| 10/04/2007 | US20070232802 Maleimide Resin With Cyanurate Core |
| 10/04/2007 | US20070232681 Compounds Having Crth2 Antagonist Activity |
| 10/04/2007 | US20070232665 Synthesis and regioselective substitution of 6-halo-and 6-alkoxy nicotine derivatives |
| 10/04/2007 | US20070232663 Small molecule insulin mimetics absent quinones |
| 10/04/2007 | US20070232662 Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders |
| 10/04/2007 | US20070232633 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agents |
| 10/04/2007 | US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents |
| 10/04/2007 | US20070232619 Piperazine Derivatives of Dialkyl Oxindoles |
| 10/04/2007 | US20070232618 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 10/04/2007 | US20070232617 Indole-type derivatives as inhibitors of p38 kinase |
| 10/04/2007 | US20070232616 [5-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-methyl-[3-(1-methyl-piperidin-4-yl)-propyl]-amine; for diseases related to H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritus |
| 10/04/2007 | US20070232615 Chemical Compounds |
| 10/04/2007 | US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/04/2007 | US20070232610 Novel compounds that are ERK inhibitors |
| 10/04/2007 | US20070232605 Inhibitors of soluble adenylate cyclase |
| 10/04/2007 | US20070232603 Small-molecule modulators of TRP-P8 activity |
| 10/04/2007 | US20070232591 such as 1-(4-Cyclobutyl-piperazin-1-yl)-2-(6-methoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethanone, used for treating attention deficit disorder, epilepsy, headaches, sleep disorders, narcolepsy, rhinitis, motion sickness, Parkinson's disease, obesity, eating disorder or diabetes |
| 10/04/2007 | US20070232590 3-Cylcoalkylbenzazepines as Histamine H3 Antagonists |
| 10/04/2007 | US20070232585 Sigma Receptor Inhibitors |
| 10/04/2007 | US20070232583 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine |
| 10/04/2007 | CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 10/04/2007 | CA2647423A1 Triazolone derivative |
| 10/04/2007 | CA2647252A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/04/2007 | CA2646952A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors |
| 10/04/2007 | CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists |
| 10/04/2007 | CA2646701A1 C-met protein kinase inhibitors for the treatment of proliferative disorders |
| 10/04/2007 | CA2645779A1 Substituted 5-hetaryl-4-aminopyrimidines |
| 10/03/2007 | EP1840126A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 10/03/2007 | EP1840122A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof |
| 10/03/2007 | EP1839659A2 Chemicals compounds |
| 10/03/2007 | EP1838703A2 Heteroaryl substituted piperazinyl-pyridine analogues |
| 10/03/2007 | EP1838702A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors |
| 10/03/2007 | EP1838701A1 N-substituted heterocyclic sulfonamides |
| 10/03/2007 | EP1838700A2 Disubstituted ureas as kinase inhibitors |
| 10/03/2007 | EP1838699A2 Method for production of candesartan |
| 10/03/2007 | EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators |
| 10/03/2007 | EP1838690A2 Compounds with kv4 ion channel activity |
| 10/03/2007 | EP1838669A1 Indoles useful in the treatment of inflammation |
| 10/03/2007 | EP1838304A2 Heterocyclic aspartyl protease inhibitors |
| 10/03/2007 | EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 10/03/2007 | EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament |
| 10/03/2007 | EP1549638B1 Indole-3-carboxamides as glucokinase (gk) activators |
| 10/03/2007 | EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/03/2007 | EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use |
| 10/03/2007 | EP1307444B1 Substituted heterocyclic amides |
| 10/03/2007 | EP1294378B1 Thrombopoietin mimetics |
| 10/03/2007 | EP1173421B1 Indole derivatives as anti-inflammation agents |
| 10/03/2007 | CN101048401A Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 10/03/2007 | CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors |
| 10/03/2007 | CN101048386A 嘧啶衍生物 Pyrimidine derivatives |
| 10/03/2007 | CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist |
| 10/03/2007 | CN101045704A An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 10/02/2007 | US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity |
| 10/02/2007 | US7276510 Viricides; prevent reproduction of human T-Cell lymphocyte virus |
| 10/02/2007 | US7276496 Cyclic malonamides as inhibitors of Aβ protein protection |
| 10/02/2007 | US7276348 Using benzodiazepine derivatives to treat and prevent defects in programed cell death, autoimmune, inflammatory and cell proliferative diseases |
| 10/02/2007 | CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 10/02/2007 | CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase |
| 10/02/2007 | CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 10/02/2007 | CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation |
| 09/27/2007 | WO2007109362A2 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses |
| 09/27/2007 | WO2007109330A2 S1p receptor modulating compounds |
| 09/27/2007 | WO2007109098A2 HYDROXY AND KETO-SUBSTITUTED β-LACTAMYL ALKANEDIOIC ACIDS |
| 09/27/2007 | WO2007109080A2 Deuterated hepatitis c protease inhibitors |